Giacomo Corrado1, Francesca Ciccarone2, Francesco Cosentino3, Francesco Legge4, Andrea Rosati2, Martina Arcieri2, Luigi Carlo Turco3,5, Camilla Certelli6, Alex Federico2, Enrico Vizza6, Francesco Fanfani2,7, Giovanni Scambia2,7, Gabriella Ferrandina2,7. 1. Department of Woman, Child Health and Public Health, Gynecologic Oncology Unit, Fondazione Policlinico Universitario A. Gemelli, IRCCS, Rome, Italy. giacomo.corrado@alice.it. 2. Department of Woman, Child Health and Public Health, Gynecologic Oncology Unit, Fondazione Policlinico Universitario A. Gemelli, IRCCS, Rome, Italy. 3. Department of Gynecologic Oncology, Gemelli Molise Spa, Università Cattolica del Sacro Cuore, Campobasso, Italy. 4. Gynecologic Oncology Unit, "F. Miulli" General Regional Hospital, Acquaviva Delle Fonti, Bari, Italy. 5. Department Gynecology and Breast Care Unit, Mater Olbia Spa, Olbia, Italy. 6. Department of Experimental Clinical Oncology, Gynecologic Oncology Unit, "Regina Elena" National Cancer Institute, IRCCS, Rome, Italy. 7. Istituto di Ostetricia e Ginecologia, Fondazione Policlinico Universitario A. Gemelli, IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy.
Abstract
OBJECTIVE: The aim of this retrospective study was to compare surgical and survival outcome in only patients with early-stage UCSs managed by laparotomic surgery (LPT) versus minimally invasive surgery (MIS). METHODS: Data were retrospectively collected in four Italian different institutions. Inclusion criteria were UCS diagnosis confirmed by the definitive histological examination, and stage I or II according to the FIGO staging system. RESULTS: Between August 2000 and March 2019, the data relative to 170 patients bearing UCSs were collected: of these, 95 were defined as early-stage disease (stage I-II) based on the histological report at the primary surgery, and thus were included in this study. Forty-four patients were managed by LPT, and 51 patients were managed by MIS. The operative time was lower in the MIS group versus the LPT group (p value 0.021); the median estimated blood loss was less in the MIS group compared to the median of LPT group (p value < 0.0001). The length of hospital stay days was shorter in the MIS patients (p value < 0.0001). Overall, there were eight (8.4%) post-operative complications; of these, seven were recorded in the LPT group versus one in the MIS group (p value 0.023). There was no difference in the disease-free survival (DFS) and overall survival (OS) between the two groups. CONCLUSION: There was no difference of oncologic outcome between the two approaches, in face of a more favourable peri-operative and post-operative profile in the MIS group.
OBJECTIVE: The aim of this retrospective study was to compare surgical and survival outcome in only patients with early-stage UCSs managed by laparotomic surgery (LPT) versus minimally invasive surgery (MIS). METHODS: Data were retrospectively collected in four Italian different institutions. Inclusion criteria were UCS diagnosis confirmed by the definitive histological examination, and stage I or II according to the FIGO staging system. RESULTS: Between August 2000 and March 2019, the data relative to 170 patients bearing UCSs were collected: of these, 95 were defined as early-stage disease (stage I-II) based on the histological report at the primary surgery, and thus were included in this study. Forty-four patients were managed by LPT, and 51 patients were managed by MIS. The operative time was lower in the MIS group versus the LPT group (p value 0.021); the median estimated blood loss was less in the MIS group compared to the median of LPT group (p value < 0.0001). The length of hospital stay days was shorter in the MIS patients (p value < 0.0001). Overall, there were eight (8.4%) post-operative complications; of these, seven were recorded in the LPT group versus one in the MIS group (p value 0.023). There was no difference in the disease-free survival (DFS) and overall survival (OS) between the two groups. CONCLUSION: There was no difference of oncologic outcome between the two approaches, in face of a more favourable peri-operative and post-operative profile in the MIS group.
Entities:
Keywords:
Minimally invasive surgery; Open surgery; Uterine carcinosarcoma
Authors: Marco A C Versluis; Cindy Pielsticker; Maaike A van der Aa; Marco de Bruyn; Harry Hollema; Hans W Nijman Journal: Oncology Date: 2018-05-23 Impact factor: 2.935
Authors: Malcolm Strachan Ross; Esther Elishaev; Jessica Layne Berger; Joseph Leo Kelley; Sarah Elizabeth Taylor Journal: Int J Gynecol Cancer Date: 2018-02 Impact factor: 3.437
Authors: Monika Janda; Val Gebski; Alison Brand; Russel Hogg; Thomas W Jobling; Russel Land; Tom Manolitsas; Anthony McCartney; Marcelo Nascimento; Deborah Neesham; James L Nicklin; Martin K Oehler; Geoff Otton; Lewis Perrin; Stuart Salfinger; Ian Hammond; Yee Leung; Tom Walsh; Peter Sykes; Hextan Ngan; Andrea Garrett; Michael Laney; Tong Yow Ng; Karfai Tam; Karen Chan; C David H Wrede; Selvan Pather; Bryony Simcock; Rhonda Farrell; Andreas Obermair Journal: Lancet Oncol Date: 2010-07-16 Impact factor: 41.316
Authors: M M Leitao; F Khoury-Collado; G Gardner; Y Sonoda; C L Brown; K M Alektiar; M L Hensley; R A Soslow; R R Barakat; N R Abu-Rustum Journal: Gynecol Oncol Date: 2013-01-12 Impact factor: 5.482
Authors: Robert W Holloway; Nadeem R Abu-Rustum; Floor J Backes; John F Boggess; Walter H Gotlieb; W Jeffrey Lowery; Emma C Rossi; Edward J Tanner; Rebecca J Wolsky Journal: Gynecol Oncol Date: 2017-05-28 Impact factor: 5.482
Authors: Martin Koskas; Marta Jozwiak; Marie Fournier; Ignace Vergote; Hans Trum; Christianne Lok; Frédéric Amant Journal: Eur J Cancer Date: 2016-08-06 Impact factor: 9.162
Authors: Joan L Walker; Marion R Piedmonte; Nick M Spirtos; Scott M Eisenkop; John B Schlaerth; Robert S Mannel; Gregory Spiegel; Richard Barakat; Michael L Pearl; Sudarshan K Sharma Journal: J Clin Oncol Date: 2009-10-05 Impact factor: 44.544
Authors: Susanna Leskela; Belen Pérez-Mies; Juan Manuel Rosa-Rosa; Eva Cristobal; Michele Biscuola; María L Palacios-Berraquero; SuFey Ong; Xavier Matias-Guiu Guia; José Palacios Journal: Cancers (Basel) Date: 2019-07-09 Impact factor: 6.639